Skip to main content

Table 7 Changes of NLR in patients of response and non-response groups

From: Post treatment NLR is a predictor of response to immune checkpoint inhibitor therapy in patients with esophageal squamous cell carcinoma

Group Trend   
Decrease Increase Total
Response 36 52 88
Non-response 1714 1417 31
Total 5350 6669 119
P value 0.679